Search Result

Pathways Recommended:	Antibody-drug Conjugate/ADC Related

Results for "

monoclonal antibody

" in MedChemExpress (MCE) Product Catalog:

By Targets:	ADC Antibody (27) ADC Linker (1) Antibody-Drug Conjugates (ADCs) (24) ADAMTS (1) ADC Cytotoxin (2) Adenosine Receptor (1) Adenylate Cyclase (1) Akt (1) ALCAM/CD166 (1) Amyloid-β (9) Anaplastic lymphoma kinase (ALK) (1) Angiotensin-converting Enzyme (ACE) (3) ANGPTL (1) Antibiotic (2) Antifolate (2) Apoptosis (24) Autophagy (1) Bacterial (10) Biochemical Assay Reagents (4) c-Fms (9) c-Kit (1) c-Met/HGFR (4) Carbonic Anhydrase (1) Caspase (1) CCR (3) CD19 (8) CD2 (1) CD20 (12) CD22 (4) CD276/B7-H3 (2) CD28 (4) CD3 (7) CD38 (7) CD47 (5) CD6 (1) CD73 (5) CD74 (1) CDK (1) CGRP Receptor (4) CMV (1) Complement System (10) CTLA-4 (13) CXCR (3) Dipeptidyl Peptidase (1) DNA/RNA Synthesis (1) Drug-Linker Conjugates for ADC (5) EGFR (39) Endothelin Receptor (1) ERK (1) Factor VIII (1) Factor Xa (2) FAP (1) FGFR (4) Filovirus (6) FLT3 (1) Fungal (1) GCGR (2) GLP Receptor (1) Glutaminase (1) Guanylate Cyclase (1) HBV (3) HDAC (1) HIV (2) IFNAR (3) IGF-1R (9) Indoleamine 2,3-Dioxygenase (IDO) (1) Influenza Virus (4) Insulin Receptor (1) Integrin (16) Interleukin Related (87) Kallikrein (1) LAG-3 (8) LPL Receptor (1) Macrophage migration inhibitory factor (MIF) (1) Microtubule/Tubulin (9) MMP (1) Monoamine Oxidase (1) Mucin (3) NAMPT (1) Nectin-4 (2) Neurotensin Receptor (1) NF-κB (3) Notch (4) Orexin Receptor (OX Receptor) (2) P-selectin (2) PARP (1) PCSK9 (6) PD-1/PD-L1 (57) PDGFR (3) PSMA (1) RABV (5) Radionuclide-Drug Conjugates (RDCs) (7) ROR (1) RSV (5) SARS-CoV (38) Ser/Thr Protease (1) Steroid Sulfatase (1) Survivin (1) TAM Receptor (1) Tau Protein (3) TGF-beta/Smad (7) TGF-β Receptor (3) Thrombin (1) Tie (2) Tim3 (1) TNF Receptor (48) Toll-like Receptor (TLR) (4) Topoisomerase (2) Transferrin Receptor (1) Trk Receptor (1) TROP2 (1) TSH Receptor (1) Tyrosinase (1) VAP-1 (2) VEGFR (15) Wnt (2) α-synuclein (2)
By Research Areas:	Cancer (399) Cardiovascular Disease (30) Endocrinology (2) Infection (78) Inflammation/Immunology (364) Metabolic Disease (28) Neurological Disease (31)

By Targets:

ADC Antibody (27)

ADC Linker (1)

Antibody-Drug Conjugates (ADCs) (24)

ADAMTS (1)

ADC Cytotoxin (2)

Adenosine Receptor (1)

Adenylate Cyclase (1)

Akt (1)

ALCAM/CD166 (1)

Amyloid-β (9)

Anaplastic lymphoma kinase (ALK) (1)

Angiotensin-converting Enzyme (ACE) (3)

ANGPTL (1)

Antibiotic (2)

Antifolate (2)

Apoptosis (24)

Autophagy (1)

Bacterial (10)

Biochemical Assay Reagents (4)

c-Fms (9)

c-Kit (1)

c-Met/HGFR (4)

Carbonic Anhydrase (1)

Caspase (1)

CCR (3)

CD19 (8)

CD2 (1)

CD20 (12)

CD22 (4)

CD276/B7-H3 (2)

CD28 (4)

CD3 (7)

CD38 (7)

CD47 (5)

CD6 (1)

CD73 (5)

CD74 (1)

CDK (1)

CGRP Receptor (4)

CMV (1)

Complement System (10)

CTLA-4 (13)

CXCR (3)

Dipeptidyl Peptidase (1)

DNA/RNA Synthesis (1)

Drug-Linker Conjugates for ADC (5)

EGFR (39)

Endothelin Receptor (1)

ERK (1)

Factor VIII (1)

Factor Xa (2)

FAP (1)

FGFR (4)

Filovirus (6)

FLT3 (1)

Fungal (1)

GCGR (2)

GLP Receptor (1)

Glutaminase (1)

Guanylate Cyclase (1)

HBV (3)

HDAC (1)

HIV (2)

IFNAR (3)

IGF-1R (9)

Indoleamine 2,3-Dioxygenase (IDO) (1)

Influenza Virus (4)

Insulin Receptor (1)

Integrin (16)

Interleukin Related (87)

Kallikrein (1)

LAG-3 (8)

LPL Receptor (1)

Macrophage migration inhibitory factor (MIF) (1)

Microtubule/Tubulin (9)

MMP (1)

Monoamine Oxidase (1)

Mucin (3)

NAMPT (1)

Nectin-4 (2)

Neurotensin Receptor (1)

NF-κB (3)

Notch (4)

Orexin Receptor (OX Receptor) (2)

P-selectin (2)

PARP (1)

PCSK9 (6)

PD-1/PD-L1 (57)

PDGFR (3)

PSMA (1)

RABV (5)

Radionuclide-Drug Conjugates (RDCs) (7)

ROR (1)

RSV (5)

SARS-CoV (38)

Ser/Thr Protease (1)

Steroid Sulfatase (1)

Survivin (1)

TAM Receptor (1)

Tau Protein (3)

TGF-beta/Smad (7)

TGF-β Receptor (3)

Thrombin (1)

Tie (2)

Tim3 (1)

TNF Receptor (48)

Toll-like Receptor (TLR) (4)

Topoisomerase (2)

Transferrin Receptor (1)

Trk Receptor (1)

TROP2 (1)

TSH Receptor (1)

Tyrosinase (1)

VAP-1 (2)

VEGFR (15)

Wnt (2)

α-synuclein (2)

By Research Areas:

Cancer (399)

Cardiovascular Disease (30)

Endocrinology (2)

Infection (78)

Inflammation/Immunology (364)

Metabolic Disease (28)

Neurological Disease (31)

611

Inhibitors & Agonists

Screening Libraries

Biochemical Assay Reagents

Peptides

MCE Kits

790

Inhibitory Antibodies

Natural
Products

Recombinant Proteins

Antibodies

Targets Recommended: ADC Antibody Antibody-Drug Conjugates (ADCs) ADC Linker PROTAC-Linker Conjugates for PAC

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-P99232

Indusatumab 5F9 monoclonal antibody	Guanylate Cyclase	Cancer
Indusatumab (5F9 Monoclonal antibody) is an anti-human GUCY2C (Guanylate cyclase 2C) monoclonal antibody .

HY-P99784

Porgaviximab	Filovirus	Infection
Porgaviximab is a monoclonal antibody that can be used Ebola infection research .

HY-P99296

Intetumumab CNTO 95; Anti-Human CD51 Recombinant antibody	EGFR	Cancer
Intetumumab (CNTO 95) is a potent anti-EGFR monoclonal antibody that is glycoengineered for enhanced antibody-dependent cellular cytotoxicity (ADCC). Intetumumab can be used in research of cancer .

HY-P99271

Tisotumab Anti-Human F3 Recombinant antibody	ADC Antibody	Cancer
Tisotumab (Anti-Human F3 Recombinant Antibody) is a human IgG1 monoclonal antibody targets tissue factor (TF). Tisotumab can be used for the research of solid tumors .

HY-P99509

Zelminemab AMG-301	Adenylate Cyclase	Neurological Disease
Zelminemab (AMG-301) is a humanized monoclonal antibody that inhibits PACAP type I (PAC1) receptor .

HY-P99295

Imgatuzumab RG 7160; RO 5083945; Anti-EGFR Recombinant antibody	EGFR	Cancer
Imgatuzumab (RG 7160) is a humanized monoclonal antibody against the EGFR. Imgatuzumab acts as an immunomodulator. Imgatuzumab can be used in research of cancer .

HY-P99453

Azintuxizumab	ADC Antibody	Cancer
Azintuxizumab is an anti-SLAMF7 human IgG4κ monoclonal antibody. Azintuxizumab can be used in the synthesis of antibody-drug conjugate (ADC), Azintuxizumab vedotin .

HY-P99825

Relfovetmab	TNF Receptor	Neurological Disease Inflammation/Immunology
Relfovetmab is an anti-NGF monoclonal antibody (mAb) .

HY-P99808

Pulocimab	VEGFR	Cancer
Pulocimab is an anti-VEGFR2 monoclonal antibody (mAb). Pulocimab can be used for the research of cancers .

HY-P99702

Levilimab BCD-089	Interleukin Related	Inflammation/Immunology
Levilimab (BCD-089) is a fully humanized anti-interleukin-6 receptor (IL-6R) monoclonal antibody. Levilimab is an inflammation-alleviating antibody. Levilimab can be used for the research of rheumatoid .

HY-P99785

Opucolimab HLX20	PD-1/PD-L1	Cancer
Opucolimab is an *anti-PD-L1* recombinant human monoclonal antibody. Opucolimab can be used to synthesis antibody agent conjugates. Opucolimab can be used for the research of advanced solid tumors .

HY-P9980

Belantamab GSK2857914	TNF Receptor ADC Antibody	Cancer
Belantamab (GSK2857914) is a humanised IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used in the synthesis of antibody-drug conjugate (ADC), Belantamab mafodotin .

HY-P99118

Serplulimab HLX 10	PD-1/PD-L1	Cancer
Serplulimab (HLX 10) is humanized monoclonal anti-PD-1 antibody. Serplulimab can be used in research of small cell lung cancer .

HY-P99850

Depemokimab GSK-3511294	Interleukin Related	Inflammation/Immunology
Depemokimab (GSK-3511294) is a long-acting anti-IL-15 monoclonal antibody. Depemokimab can be used for research of asthma .

HY-157190

Fenhexamid-butyric acid	Others	Inflammation/Immunology
Fenhexamid-butyric acid (Compound FHo) is a hapten designed based on fenhexamid, which can produce monoclonal antibodies with an IC₅₀ value of 0.66-0.93 nM .

HY-P9969

Matuzumab EMD 72000	EGFR	Cancer
Matuzumab (EMD 72000) is a humanized anti-EGFR monoclonal antibody that blocks EGFR activation and downstream signaling, inhibits tumor growth .

HY-P99616

Felzartamab MOR-202	CD38	Cancer
Felzartamab (MOR-202) is a human monoclonal antibody that targets CD38 and can be used in multiple myeloma research .

HY-P99854

Disitamab RC48-0	EGFR ADC Antibody	Cancer
Disitamab (RC48-0) is a humanized monoclonal antibody targeting HER2. Disitamab can be used in the synthesis of antibody-drug conjugates (ADCs), Disitamab vedotin (Disitamab vedotin (HY-P9985)) .

HY-P99855

Divozilimab BCD-132	CD20	Inflammation/Immunology
Divozilimab (BCD-132) is a humanised monoclonal antibody against CD20 (CD20). Divozilimab can be used for multiple sclerosis research .

HY-P99779

Plonmarlimab TJ003234; TJM2	c-Fms SARS-CoV	Infection Inflammation/Immunology
Plonmarlimab (TJ003234) is an anti-GM-CSF monoclonal antibody. Plonmarlimab can be used for research of rheumatoid arthritis and COVID-19 .

HY-P99760

Nurulimab BCD-145	CTLA-4	Cancer
Nurulimab (BCD-145) is an anti-cytotoxic T lymphocyte antigen-4 (anti-CTLA-4) human monoclonal antibody. Nurulimab can be can be used in research of melanoma .

HY-P99324

Tomuzotuximab Anti-Human EGFR Recombinant antibody	EGFR Apoptosis	Cancer
Tomuzotuximab (Anti-Human EGFR Recombinant Antibody) is a fully human glycoengineered IgG1 monoclonal antibody against EGFR. Tomuzotuximab has anticancer effects .

HY-156035

Bz-DTPA	Others	Inflammation/Immunology
Bz-DTPA is a bifunctional chelator. Bz-DTPA can be used for preparing immunoconjugate of monoclonal antibody 2G3 labeled with indium-111 .

HY-P9922

Olaratumab IMC-3G3; LY3012207	PDGFR	Cancer
Olaratumab (IMC-3G3; LY3012207) is an anti-platelet-derived growth factor receptor alpha (PDGFRα) human monoclonal IgG1 antibody with antitumor activity .

HY-P99210

Olokizumab CDP 6038; OKZ	Interleukin Related	Inflammation/Immunology
Olokizumab (CDP 6038) is a humanized monoclonal antibody targeting the interleukin-6 (IL-6). Olokizumab can be used in research of rheumatoid arthritis (RA) .

HY-P99820

Ranevetmab NV-01	TNF Receptor	Inflammation/Immunology
Ranevetmab (NV-01) is a caninised anti-NGF monoclonal antibody (mAb). Ranevetmab can alleviate pain, and is used for the research of degenerative joint disease (DJD) pain .

HY-P9919

Durvalumab 5 Publications Verification MEDI 4736	PD-1/PD-L1	Cancer
Durvalumab (MEDI 4736) is an human anti-PD-L1 monoclonal antibody . Durvalumab (MEDI4736) completely blocks the binding of PD-L1 to both PD-1 and CD80, with IC₅₀s of 0.1 and 0.04 nM, respectively .

HY-P99628

Futuximab	EGFR	Cancer
Futuximab is a chimeric monoclonal antibody targeting non-overlapping epitopes on EGFR. Futuximab has antineoplastic activity .

HY-P99246

Bermekimab MABp1	Interleukin Related	Inflammation/Immunology Cancer
Bermekimab (MABp1) is a human monoclonal antibody that targets interleukin-1alpa (IL-1α). Bermekimab prevents tumour-related inflammation .

HY-P99380

Zanidatamab 1 Publications Verification ZW 25	EGFR	Cancer
Zanidatamab (ZW25) is a humanised, bispecific monoclonal antibody targeting 2 distinct HER2 epitopes (ECD2 and ECD4). Zanidatamab has anti-tumour activity .

HY-P99022

Gantenerumab	Amyloid-β	Neurological Disease
Gantenerumab is a fully human anti-amyloid-β (Aβ) IgG1 monoclonal antibody demonstrates sustained cerebral amyloid-β binding. Gantenerumab can be used for Alzheimer's disease research .

HY-P99234

Pivekimab	Interleukin Related ADC Antibody	Cancer
Pivekimab is a human IgG1 monoclonal antibody that targets interleukin-3 (IL-3) and CD123. Pivekimab is used to synthesize pivekimab sunirine, a CD123-directed antibody-active molecule conjugate (ADC). Pivekimab is used in the study of blastic plasmacytoid dendritic cell neoplasm (BPDCN) .

HY-P99042

Polatuzumab 1 Publications Verification	ADC Antibody	Cancer
Polatuzumab is a monoclonal antibody, which targets CD79b that is found on the surface of B cells. Polatuzumab sticks to the CD79b protein and delivers the chemotherapy compound into the cell. Polatuzumab can be used to synthesize Polatuzumab Vedotin, which is an antibody-drug conjugate (ADC) targeting CD79b .

HY-P9938

Erenumab	CGRP Receptor	Others
Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine .

HY-147407

Imbotolimod	Others	Cancer
Imbotolimod, immunoglobulin G1-kappa, is a humanized monoclonal antibody with *anti-ERBB2* and antineoplastic activity. Imbotolimod is a derivative of telratolimod .

HY-P99269

Sibrotuzumab BIBH 1; Anti-Human FAP Recombinant antibody	FAP	Cancer
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targets fibroblast activation protein (FAP). Sibrotuzumab can be used for the research of colorectal cancer and non-small cell lung cancer (NSCLC) .

HY-P99695

Lerdelimumab CAT-152	TGF-beta/Smad	Neurological Disease
Lerdelimumab (CAT-152) is an IgG4 human *anti-TGF-β2* recombinant monoclonal antibody. Lerdelimumab can be used as an anti-scarring agent for glaucoma research .

HY-P99310

Perakizumab RG4934	Interleukin Related	Inflammation/Immunology
Perakizumab (RG4934) is a humanized IgG1κ monoclonal antibody against IL-17A (Interleukin Related). Perakizumab can be uesd for the research of autoimmune diseases, such as psoriatic arthritis .

HY-P99017

Eptinezumab	CGRP Receptor	Others
Eptinezumab is a humanized monoclonal antibody. Eptinezumab binds to calcitonin gene-related peptide (CGRP) and blocks its interaction with the receptor. Eptinezumab is used for the prevention of migraine in adults .

HY-P99773

Ongericimab JS002	PCSK9	Cardiovascular Disease Metabolic Disease
Ongericimab (JS002) is a humanized anti-PCSK9 monoclonal antibody. Ongericimab has lipid-lowering efficacy. Ongericimab can be used in research of hypercholesteremia and hyperlipidemia .

HY-P9962

Efungumab	Fungal	Infection
Efungumab is a monoclonal antibody with antifungal activity. Efungumab binds to HSP 90, preventing a conformational change needed for fungal viability. Efungumab can be used for research on invasive candidiasis (IC) .

HY-P99556

Tixagevimab AZD8895	SARS-CoV	Infection
Tixagevimab (AZD8895) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor .

HY-D1710

Anti-α-Tubulin Antibody, AF555 conjugate	Microtubule/Tubulin	Others
Anti-α-Tubulin Antibody, AF555 conjugate is a conjugate of mouse anti-α-tubulin monoclonal antibody and the red fluorescent dye Alexa Fluor 555. Anti-α-Tubulin Antibody, AF555 conjugate can be used for the detection of tubulin (Ex/Em: 554/567 nm) .

HY-P99372

Lorvotuzumab Anti-NCAM1/ CD56 Reference antibody (lorvotuzumab)	ADC Antibody	Cancer
Lorvotuzumab (Anti-NCAM1/CD56 Reference Antibody (lorvotuzumab)) is a humanized monoclonal antibody that binds CD56 (NCAM1). Lorvotuzumab can be used to synthesize an ADC compound, Lorvotuzumab mertansine .

HY-P99374

Naratuximab Anti-TSPAN26/CD37 Reference antibody (naratuximab)	ADC Antibody	Cancer
Naratuximab (Anti-TSPAN26/CD37 Reference Antibody (naratuximab)) is a humanized monoclonal antibody that binds CD37 (TSPAN26). Naratuximab can be used to synthesize an ADC compound, Naratuximab emtansine .

HY-P99514

Zalifrelimab AGEN1884	CTLA-4	Cancer
Zalifrelimab (AGEN1884) is a fully human IgG1 monoclonal antibody targeting CTLA-4 (CTLA-4). Zalifrelimab antagonizes the inhibitory checkpoints of immune cell activation regulated by CTLA-4 signaling .

HY-P99538

Ublituximab LFB-R603; TG-1101; TGTX-1101	CD20	Cancer
Ublituximab (LFB-R603; TG-1101; TGTX-1101) is a next-generation, type 1 chimeric monoclonal antibody targeting a unique epitope on the CD20 antigen. Ublituximab has anticancer effects .

HY-P99624

Foravirumab CR4098	RABV	Infection
Foravirumab (CR4098) is a monoclonal antibody against rabies virus glycoprotein antigenic site III .

HY-P99027

Ieramilimab LAG525; IMP701	LAG-3	Cancer
Ieramilimab (LAG525; IMP701) is a humanized IgG4 monoclonal antibody that binds to LAG-3, resulting in inhibition of LAG-3 interaction with MHC-II molecules .

HY-P99465

Befovacimab BAY 1093884	Thrombin	Cardiovascular Disease
Befovacimab (BAY 1093884) is a fully human monoclonal IgG2 antibody able to bind to tissue factor pathway inhibitor (TFPI). Befovacimab can be used for haemophilia A/B research .

Cat. No.	Product Name

HY-L080

Targeted Therapy Drug Library

107 compounds

Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecular targets that are involved in the growth, progression, and spread of cancer.

There are several different types of targeted therapy. The most common types are small-molecule drugs and monoclonal antibodies. Small-molecule drugs are small enough to enter cells easily, so they are used for targets that are inside cells, while monoclonal antibodies are usually used for targets that are located outside the cells. Because of high specificity, low side effect and potent anticancer activity, targeted therapy has become the mainstream of new anti-tumor drugs. Various targeted therapies have been approved by FDA and used in the treatment of diseases.

MCE carefully collects a unique of 107 targeted therapy drugs used in cancer treatment. MCE Targeted therapy drug library is a useful tool for the research of targeted therapy.

HY-L023

Toxins for Antibody-Drug Conjugate Research Library

104 compounds

Antibody-Drug Conjugates (ADCs), a new class of treatment for cancer, are composed with a monoclonal antibody, a linker and a cytotoxic agent also referred to as a payload. To date, several ADCs have received market approval and more than 60 ADCs are currently in clinical trials. ADCs are one of the fastest growing classes of oncology drugs worldwide.

The payload or cytotoxic agent is the most important unit in the ADC. ADC has the capability to kill cancer cell depending on the potency of the payload. MCE provides 104 highly potent cytotoxins that contain auristatin derivatives, maytansinoids, calicheamicin, duocarmycin, pyrrolobenzodiazepines (PBDs), etc.

HY-L031

Small Molecule Immuno-Oncology Compound Library

494 compounds

Immuno-Oncology is a type of immunotherapy that has the specific purpose of treating cancer. It works by stimulating our immune system to fight back. Normally, our immune system is able to destroy cancer cells in our body, however sometimes cancer cells can adapt and mutate, effectively hiding from our immune system. This is when tumors can develop and become a threat to our health. Immuno-oncology involves mobilizing lymphocytes to recognize and eliminate cancer cells using the body’s immune system. There are several immuno-oncology treatments available, including Immune cell therapy (CAR-T), monoclonal antibodies (mABs) and checkpoint inhibitors, cytokines and cancer vaccines.

MCE Small Molecule Immuno-Oncology Compound Library offers 494 bioactive tumor immunology compounds that target some important checkpoints such as PD1/PD-L1, CXCR, Sting, IDO, TLR, etc. This library is a useful tool for Immuno-oncology research.

Cat. No.	Product Name	Type

HY-154818

Bovine Serum Albumin, Acetylated

Ac-BSA

Native Proteins

Bovine Serum Albumin, Acetylated (Ac-BSA) is a polypeptide of known structure with strong antigenicity. Bovine Serum Albumin, Acetylated produced a significant immune response, validating the accuracy and reliability of the experimental method. Bovine Serum Albumin, Acetylated can be used as a positive control substance in ELISA or WB experiments, and can be used in experiments with acetylated lysine monoclonal or polyclonal antibodies. Bovine Serum Albumin, Acetylated also improves encapsulation efficiency at low concentrations of PLGA, a polymer for biopharmaceutical delivery with biocompatibility, degradability, and controlled release properties .

HY-D1056A3

Lipopolysaccharides, from E. coli O26:B6

LPS, from Escherichia coli (O26:B6)

Carbohydrates

Lipopolysaccharides, from E. coli O26:B6 is a lipopolysaccharide endotoxin and TLR-4 activator that activates the disease-related molecular pattern (PAMP) of the immune system and induces cell secretion of migratory bodies. Lipopolysaccharides, from E. coli O26:B6 consists of an antigen-specific O-chain, some cells lack an O-antigen-side chain, and is recognized by the core-specific monoclonal antibody MAb J8-4C10 .

Cat. No.	Product Name	Target	Research Area

HY-P3149B

LEESGGGLVQPGGSMK acetate	TNF Receptor	Inflammation/Immunology
LEESGGGLVQPGGSMK acetate, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK acetate can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .

HY-P3203A

DSTYSLSSTLTLSK TFA	TNF Receptor	Inflammation/Immunology
DSTYSLSSTLTLSK TFA is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.

HY-P10544

Humanized anti-tac (HAT) binding peptide	Peptides	Others
Humanized anti-tac (HAT) binding peptide is a peptide that can specifically bind to the Fc region of HAT. HAT is a humanized monoclonal antibody against the low affinity p55 subunit of the interleukin IL-2 receptor. Humanized anti-tac (HAT) binding peptide can be used to develop affinity chromatography media to purify specific monoclonal antibodies .

HY-P4025

ELDKWA	Peptides	Others
ELDKWA is the highly conserved amino acids on the ecto-domain of gp41. ELDKWA acts as the epitope of a neutralizing monoclonal antibody 2F5 (mAb 2F5) directed against human immunodeficiency virus type 1 .

HY-P3893

PSTAIR	CDK	Metabolic Disease
PSTAIR is a monoclonal antibody that recognizes the PSTAIR sequence in Cdc28, PSTAIR can be used as loading control .

HY-P3149

LEESGGGLVQPGGSMK	TNF Receptor	Inflammation/Immunology
LEESGGGLVQPGGSMK, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .

HY-P3203

DSTYSLSSTLTLSK	Peptides	Inflammation/Immunology
DSTYSLSSTLTLSK is a generic human peptide and can be used for infliximab quantitative detection . Infliximab (Avakine) is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α.

HY-P3149A

LEESGGGLVQPGGSMK TFA	TNF Receptor	Inflammation/Immunology
LEESGGGLVQPGGSMK TFA, a proteolysis peptide, is a component of Infliximab. LEESGGGLVQPGGSMK TFA can be used for quantitative analysis of Infliximab. Infliximab is a chimeric monoclonal IgG1 antibody that specifically binds to TNF-α .

HY-P4810

Polyphemusin II-Derived Peptide T140	CXCR	Infection
Polyphemusin II-Derived Peptide (T140), a CXCR4 inhibitor, shows high inhibitory activity against HIV-1 entry and the inhibitory effect on the binding of an anti-CXCR4 monoclonal antibody (12G5) to CXCR4 .

HY-P5413

[Lys3]-Bombesin	Peptides	Others
[Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)

Cat. No.	Product Name

HY-K0213

Protein A Agarose 1 Publications Verification
MCE Protein A Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein A, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG, IgE, IgM.

HY-K0215

Protein L Agarose
MCE Protein L Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein L, effectively purifies mammalian monoclonal and polyclonal antibodies which have kappa light chain.

HY-K0214

Protein G Agarose 2 Publications Verification
MCE Protein G Agarose, a 4% highly cross-linked agarose reagent coupled with recombinant Protein G, effectively purifies mammalian monoclonal and polyclonal antibodies, such as human IgG3 and rat IgG2a.

Cat. No.	Compare	Product Name	Species	Source

HY-P703485

	ScFv16 Protein, Mouse (Sf9) Ig kappa chain V-II region 7S34.1; Mus musculus; Mouse; monoclonal antibody	Mouse	Sf9 insect cells
	ScFv16 Protein, Mouse (Sf9) is the recombinant mouse-derived ScFv16, expressed by Sf9 insect cells , with tag Free labeled tag. ,

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Compare	Product Name	Application	Reactivity

HY-P81234

	Ki-67 Antibody 1 Publications Verification Antigen identified by monoclonal antibody Ki 67; Antigen KI67; KIA; Ki67; MKI67; Proliferation related Ki 67 antigen; Antigen KI-67; KI67_MOUSE.	IHC-P, IHC-F, ICC/IF	Human
	Ki-67 Antibody is an unconjugated, approximately 358 kDa, rabbit-derived, anti-Ki-67 polyclonal antibody. Ki-67 Antibody can be used for: IHC-P, IHC-F, ICC, IF expriments in human background without labeling.